Literature DB >> 15793142

Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea.

Jungmin Kim1, Yu-Mi Lim, Young-Sook Jeong, Sung-Yong Seol.   

Abstract

Among 603 isolates of Enterobacteriaceae collected between June and November 2003 from three university hospitals within Korea, bla(CTX-M-3), bla(CTX-M-15), bla(CTX-M-14), and bla(CTX-M-9) were detected in 41 isolates of species from five different genera of Enterobacteriaceae, Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter spp., and Serratia marcescens.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793142      PMCID： PMC1068616          DOI： 10.1128/AAC.49.4.1572-1575.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea.

Authors:  H Pai; E H Choi; H J Lee; J Y Hong; G A Jacoby
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 3.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

5.  Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.

Authors:  H Pai; S Lyu; J H Lee; J Kim; Y Kwon; J W Kim; K W Choe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.

Authors:  L Poirel; T Naas; I Le Thomas; A Karim; E Bingen; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191
  6 in total
  24 in total

1.  Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.

Authors:  Cheol-In Kang; Yu Mi Wi; Mi Young Lee; Kwan Soo Ko; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Jérôme Moreau; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

3.  Characterization of conjugative plasmids carrying antibiotic resistance genes encoding 16S rRNA methylase, extended-spectrum beta-lactamase, and/or plasmid-mediated AmpC beta-lactamase.

Authors:  Hee Young Kang; Jungmin Kim; Sung Yong Seol; Yoo Chul Lee; Je Chul Lee; Dong Taek Cho
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

4.  Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy.

Authors:  Jean-Philippe Lavigne; Adeline Boutet-Dubois; Dorsaf Laouini; Christophe Combescure; Nicole Bouziges; Pierre Marès; Albert Sotto
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

5.  Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.

Authors:  Migma Dorji Tamang; Hyang-Mi Nam; Tae-Sun Kim; Geum-Chan Jang; Suk-Chan Jung; Suk-Kyung Lim
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

6.  Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.

Authors:  Johann D D Pitout; Kevin B Laupland; Deirdre L Church; Megan L Menard; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Authors:  Nuno Mendonça; Joana Leitão; Vera Manageiro; Eugénia Ferreira; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

8.  In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.

Authors:  Min Kyeong Cha; Cheol-In Kang; So Hyun Kim; Sun Young Cho; Young Eun Ha; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

9.  qnrA in CTX-M-producing Escherichia coli isolates from France.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

10.  Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria.

Authors:  A Agabou; N Lezzar; Z Ouchenane; S Khemissi; D Satta; A Sotto; J-P Lavigne; A Pantel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-03       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.